Clinical Scorecard: The Changing Economics of Retina
At a Glance
| Category | Detail |
|---|---|
| Condition | Vitreoretinal Procedures |
| Key Mechanisms | Rising procedure volume with declining reimbursement rates |
| Target Population | Medicare beneficiaries requiring vitreoretinal care |
| Care Setting | Outpatient and surgical settings |
Key Highlights
- Vitreoretinal procedure volume increased sixfold from 2000 to 2021.
- Inflation-adjusted reimbursement declined by an average of 32%.
- Intravitreal injections rose over 1,100-fold in volume.
- Significant declines in reimbursement for 29 of 38 procedures analyzed.
- Concerns raised about sustainability of surgical retinal care access.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
- Access to surgical retinal care may be compromised due to declining reimbursements.
Patient & Prescribing Data
Medicare beneficiaries undergoing vitreoretinal procedures
Increased volume of procedures despite significant reimbursement cuts.
Clinical Best Practices
- Monitor changes in procedure volume and reimbursement trends.
- Evaluate the financial sustainability of vitreoretinal practices.
- Consider patient access issues in surgical retinal care.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







